Machine learning predictions based on historical earnings data and price patterns
1-Day Prediction
+1.52%
$49.98
100% positive prob.
5-Day Prediction
+2.68%
$50.55
100% positive prob.
20-Day Prediction
+1.35%
$49.89
95% positive prob.
| Quarter | Signal | 1D Return | 5D Return | 20D Return | Confidence | Actual 5D |
|---|---|---|---|---|---|---|
| Q1 2026 | BUY | +1.52% | +2.68% | +1.35% | 100.0% | Pending |
| Q4 2025 | BUY | +1.06% | +2.48% | +2.75% | 100.0% | +3.88% |
SEC 8-K filings with transcript text
May 5, 2026 · 100% conf.
1D
+1.52%
$49.98
5D
+2.68%
$50.55
20D
+1.35%
$49.89
2 exhibit991enrschedules-1q26.htm
Document
Exhibit 99.1
DuPont Reports First Quarter 2026 Results
Exceeds First Quarter 2026 Guidance
Raises Full Year 2026 Guidance
First Quarter 2026 Highlights
•Net Sales of $1.7 billion increased 4%; organic sales increased 2% versus year-ago period
•GAAP Income from continuing operations of $150 million; operating EBITDA of $414 million
• GAAP EPS from continuing operations of $0.36; adjusted EPS of $0.55
• Cash provided by operating activities from continuing operations of $232 million; transaction-adjusted free cash flow of $147 million
• Completed the previously announced divestiture of the Aramids business on April 1st
• Announces $275 million accelerated share repurchase expected to be launched imminently
WILMINGTON, Del., May 5, 2026 - DuPont (NYSE: DD) announced its financial results(1) for the first quarter ended March 31, 2026 and raised financial guidance for the full year 2026.
“We delivered a strong start to the year, exceeding our financial guidance through disciplined commercial and operational execution” said Lori Koch, DuPont Chief Executive Officer. “Our teams remained focused on our customers and delivered organic growth, margin expansion, and double-digit adjusted EPS growth, along with solid cash flow generation in the quarter.”
“Our strategic priorities are clear and we remain focused on value creation by serving our customers, driving commercial and operational excellence and allocating capital thoughtfully to deliver consistent performance to our shareholders,” Koch concluded.
First Quarter 2026 Consolidated Results(1)
Dollars in millions, except EPS
Change
vs. 1Q’25
Organic Sales (2)
vs. 1Q’25
Net sales$1,681$1,6124%2%
GAAP Income from continuing operations$150$8088%
Operating EBITDA(2) $414$36015%
Operating EBITDA margin(2) % 24.6%22.3%230 bps
GAAP EPS from continuing operations$0.36$0.1989%
Adjusted EPS(2) $0.55$0.3653%
Cash provided by operating activities – cont. ops.$232$77201%
Transaction-adjusted free cash flow(2)
$147$8n.m
(1)Results and cash flows are presented on a continuing operations basis. See page 6 for further information, including the basis of presentation included in this release.
(2)Organic sales, operating EBITDA, operating EBITDA margin, adjusted EPS, transaction-adjusted free cash flow and transaction-adjusted free cash flow conversion are non-GAAP measures and only reflect continuing operations. See page 6 for further discussion, including a definition of significant items. Reconciliation to the most directly comparable GAAP measure, including details of significant items begins on page 13 of this communication.
Net sales
•Net sales were up 4% on a 2% increase in organic sales and a 2% currency benefit.
• 3% organic sales growth in Healthcare & Water Technologies; about flat organic sales growth in Diversified Industrials.
GAAP Income from continuing operations
•GAAP Income/GAAP EPS from continuing operations improved on higher segment earnings and lower interest expense, partially offset by the absence of a prior year gain on interest rate swaps.
Operating EBITDA
•Operating EBITDA increased on organic growth, favorable mix and productivity.
Adjusted EPS
•Adjusted EPS increased on higher segment earnings and lower interest expense, corporate costs and tax rate.
Cash provided by operating activities from continuing operations
•Cash provided by operating activities from continuing operations in the quarter of $232 million, capital expenditures of $102 million and separation-related transaction costs and other payments of $17 million resulted in transaction-adjusted free cash flow and related conversion of $147 million and 65%, respectively.
First Quarter 2026 Segment Highlights
Healthcare & Water Technologies
Dollars in millions
Change
vs. 1Q’25
Organic Sales(2)
vs. 1Q’25
Net sales$806$7636%3%
Operating EBITDA$244$2239%
Operating EBITDA margin %30.3%29.2%110 bps
Net sales
•Net sales increased 6% on organic sales growth of 3% and a currency benefit of 3%.
◦Healthcare Technologies sales up high-single digits on an organic basis on broad-based growth led by medical packaging and biopharma.
◦Water Technologies sales down low to mid-single digits on an organic basis as strength in industrial water and microelectronics markets were more than offset by logistics disruptions in the Middle East.
Operating EBITDA
•Operating EBITDA increased on organic growth and productivity.
• Operating EBITDA margin of 30.3% increased 110 basis points on organic growth, favorable mix and productivity.
2
Diversified Industrials
Dollars in millions
1Q’25Change vs. 1Q’25 Organic Sales(2)
vs. 1Q’25
Net sales$875$8493%~flat
Operating EBITDA$200$1858%
Operating EBITDA margin %22.9%21.8%110 bps
Net sales
•Net sales increased 3% on a currency benefit of 3%. Organic sales were about flat in the quarter.
◦Building Technologies sale
Feb 10, 2026 · 100% conf.
1D
+1.06%
$49.96
Act: +4.25%
5D
+2.48%
$50.66
Act: +3.88%
20D
+2.75%
$50.79
dd-202602100001666700false00016667002026-02-102026-02-10
Washington, D.C. 20549
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 10, 2026
DuPont de Nemours, Inc. (Exact name of registrant as specified in its charter)
Delaware 001-38196 81-1224539
(State or other jurisdiction of incorporation)(Commission file number) (IRS Employer Identification No.)
974 Centre Road, Building 730Wilmington, Delaware19805 (Address of Principal Executive Offices) (Zip Code)
(302) 295-5783 (Registrant’s Telephone Number, Including Area Code)
Not applicable (Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Title of each classTrading Symbol(s)Name of each exchange on which registered Common Stock, par value $0.01 per shareDDNew York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Section 2 - Financial Information Item 2.02 Results of Operations and Financial Condition.
On February 10, 2026, DuPont de Nemours, Inc. (the "Company") issued a press release, attached as Exhibit 99.1, and incorporated herein by reference, announcing results for the fourth quarter and full year 2025.
The information contained in this report, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, (the "Exchange Act") or otherwise subject to the liabilities of Section 18. Furthermore, the information contained in this report shall not be deemed to be incorporated by reference into any registration statement or other document filed pursuant to the Securities Act of 1933, as amended.
Section 9 - Financial Statements and Exhibits Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
99.1 Press release issued by DuPont de Nemours, Inc. on February 10, 2026, announcing results for the fourth quarter 2025. 104The cover page from this Current Report on Form 8-K, formatted in Inline XBRL.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Registrant Date: February 10, 2026
By:/s/ Madeleine G. Barber Name:Madeleine G. Barber Title:Vice President of Tax, Controller and Chief Accounting Officer
Nov 6, 2025
dd-202511060001666700false00016667002025-11-062025-11-06
Washington, D.C. 20549
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 6, 2025
DuPont de Nemours, Inc. (Exact name of registrant as specified in its charter)
Delaware 001-38196 81-1224539
(State or other jurisdiction of incorporation)(Commission file number) (IRS Employer Identification No.)
974 Centre Road, Building 730Wilmington, Delaware19805 (Address of Principal Executive Offices) (Zip Code)
(302) 295-5783 (Registrant’s Telephone Number, Including Area Code)
Not applicable (Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Title of each classTrading Symbol(s)Name of each exchange on which registered Common Stock, par value $0.01 per shareDDNew York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Section 2 - Financial Information Item 2.02 Results of Operations and Financial Condition.
On November 6, 2025, DuPont de Nemours, Inc. (the "Company") issued a press release, attached as Exhibit 99.1, and incorporated herein by reference, announcing results for the third quarter 2025.
The information contained in this report, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, (the "Exchange Act") or otherwise subject to the liabilities of Section 18. Furthermore, the information contained in this report shall not be deemed to be incorporated by reference into any registration statement or other document filed pursuant to the Securities Act of 1933, as amended.
Section 9 - Financial Statements and Exhibits Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
99.1 Press release issued by DuPont de Nemours, Inc. on November 6, 2025, announcing results for the third quarter 2025. 104The cover page from this Current Report on Form 8-K, formatted in Inline XBRL.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Registrant Date: November 6, 2025
By:/s/ Madeleine G. Barber Name:Madeleine G. Barber Title:Vice President of Tax, Controller and Chief Accounting Officer
This page provides DuPont de Nemours Inc. (DD) earnings call transcripts from SEC 8-K filings along with AI-powered predictions for post-earnings price movements. Our machine learning models analyze historical earnings data, pre-earnings price patterns, volume changes, and volatility to predict 1-day, 5-day, and 20-day returns after each earnings release.
Earnings transcripts are sourced directly from SEC EDGAR filings. Predictions are generated using gradient boosting models trained on DD's historical earnings reactions. All predicted returns are shown as percentages, and predicted prices are calculated from the closing price at the time of prediction. Past performance does not guarantee future results.